Shoni Health Ventures

VOLL Medical Technologies is a company engaged in the development of innovative medical solutions, currently operating in stealth mode. This approach allows the firm to focus on research and development without public scrutiny or competition. While specific products or technologies have not been disclosed, the company's commitment to advancing medical technology indicates a forward-thinking strategy aimed at addressing unmet needs within the healthcare sector. Their operations reflect a dedication to creating impactful solutions, although details on their offerings and target markets remain under wraps as they continue to refine their innovations.

Fully automated diagnosis, interpretation & reporting of ultrasound examinations at the point of care.

Lin Health is a digital health company focused on providing comprehensive care for individuals suffering from chronic pain. It offers personalized, science-based programs that integrate behavioral health therapies and non-opioid treatments. By utilizing telehealth services, Lin Health connects patients to a remote care system, allowing for effective management of their pain and addressing unmet therapeutic needs. The company's approach emphasizes the importance of expert guidance and support, ensuring that patients receive tailored care plans designed to enhance their overall well-being.

QuantHealth is a company focused on enhancing drug development through artificial intelligence-based software. This software is designed to conduct patient-centric simulations that accelerate and de-risk the drug development process. By integrating diverse data points from the clinical and drug development landscape, QuantHealth predicts patient responses to both existing and new therapies. This capability allows pharmaceutical and biotechnology firms to explore various scenarios within their clinical trials, optimizing trial designs and improving the likelihood of successful outcomes. Ultimately, QuantHealth's solutions facilitate the discovery of new clinical opportunities and strategies for optimizing drug development.

FeelBetter is a healthcare optimization platform founded in 2018 and based in Tel Aviv, Israel. The company focuses on value-based models to identify at-risk patients and appropriate interventions. Its platform enhances financial and clinical outcomes by analyzing individual patients' health journeys and diagnosing necessary interventions before deterioration occurs. By delivering personalized data and actionable insights, FeelBetter enables healthcare organizations to improve patient outcomes and overall business results.

Append Medical is a medical technology company focused on developing an innovative transcatheter Left Atrial Appendage (LAA) closure system aimed at preventing strokes by reducing the risk of blood clots traveling to the brain. The company’s approach involves a uniquely designed system that eliminates the LAA through tissue invagination and suture closure, providing a simplified alternative to traditional implant-based LAA closures. This method is intended to minimize the presence of foreign materials at the closure site, thereby reducing device-related thromboembolism risks. Currently in the pre-clinical in-vivo trial phase, Append Medical operates within a market projected to grow significantly, with estimates suggesting the LAA closure market could reach $25 billion in the coming years. The company is also affiliated with MEDX Xelerator, a medtech incubator supported by several prominent organizations.

Stealth mode

Fully automated diagnosis, interpretation & reporting of ultrasound examinations at the point of care.